.jpg)
Market Access Matters
Brought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
Episodes
28 episodes
Elevating launch excellence: The strategic value of early market access involvement with Lizzie Shanahan, Sanofi
In this insightful episode we speak with Lizzie Shanahan, Global Access AI Strategy Lead at Sanofi. With over six years' experience at Sanofi and a rich background in commercial roles, Lizzie shares her unique journey into the world of market a...
•
Season 4
•
Episode 5
•
30:22
.jpg)
Getting ready for the JCA: Why cross-functional collaboration matters with Silvy Mardiguian, BeiGene
In this episode, we speak with Silvy Mardiguian, Senior Director and Head of HEOR for Europe & New Markets at BeiGene. Silvy has been co-leading BeiGene’s preparedness and organisational readiness for the new Joint Clinical Ass...
•
Season 4
•
Episode 4
•
18:35
.jpg)
The rise of multi-stakeholder capitalism in market access with Jie Shen, CSL
In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL. Having started her career in pharma before the market access function existed, Jie is an industry veteran. We cover the changes she's se...
•
Season 4
•
Episode 3
•
13:37
.jpg)
Authentic leadership in Market Access with Katrin Jack, Galderma
We're kicking off 2025 with a fantastic podcast episode featuring Katrin Jack, Global Access Strategy Head at Galderma and President of the Healthcare Businesswomen's Association Zürich-Zug Chapter. This episode covers a lot of grou...
•
Season 4
•
Episode 2
•
42:03
.jpg)
Market Access in emerging markets with Ezgi Erdogan, GSK
In this episode we speak with Ezgi Erdogan who is Oncology Market Access Director for Emerging Markets at GSK. In this discussion, we cover the unpredictability of emerging markets and the unique challenges this presents. Ezgi also...
•
Season 4
•
Episode 1
•
15:05
.jpg)
Why Market Access requires unique thinking with UCB's Pauline Payen
In this episode, we sit down with Pauline Payen, Director and Global Payer Strategy Lead for UCB’s Early Portfolio. Pauline shares her pragmatic insights into navigating the complexities of global market access. Throughout her car...
•
Season 3
•
Episode 8
•
27:41
.jpg)
The role of resilience in market access with Rupert Gale from GSK
In this episode we're joined by GSK's Head of Market Access for General Medicines, Rupert Gale. Rupert has been in pharma for over 27 years and is still going strong! In this discussion, he shares what resilience means to him and w...
•
Season 3
•
Episode 7
•
29:06
.jpg)
Exploring value demonstration in market access with Korinna Karampampa, CSL Behring
Korinna Karampampa, who is Director Market Access and Pricing at CSL Behring, joins this episode to share her views on sustainable economic development. Korinna shares what led her into market access and explains what drives her to...
•
Season 3
•
Episode 6
•
14:28
.jpg)
Connecting the dots: Market access in the biotech industry with Ning Lu, Blueprint Medicines
In this episode we're joined by our first guest from Biotech - Ning Lu, who is Associate Director, International Pricing & Market Access at Blueprint Medicines.Ning shares her views on the complexities of market access and what make...
•
Season 3
•
Episode 6
•
16:21
.jpg)
What it takes to thrive as a strategic partner in market access with Marco Rauland, Merck KGaA
There’s no doubt that Market Access and Pricing leaders are fast becoming strategic partners in helping their wider organisations to understand the critical role of the function. In this episode, Marco Rauland from Merck KGaA joins us to explor...
•
Season 3
•
Episode 5
•
18:05
.jpg)
Yvonne Hilsky, Moderna, on why it's important to understand the building blocks of market access.
In this episode we're joined by Yvonne Hilsky who is Director of Market Access at Moderna. Having spent over 30 years in industry, Yvonne shares her views on what it takes to be successful in market access, including why making mistakes are an ...
•
Season 3
•
Episode 4
•
19:25
.jpg)
Raising awareness on Disability with Shubham Jadhav
In this special episode which coincides with Disability Pride Month, we're joined by Senior Analyst Shubham Jadhav. Shubham has Becker Muscular Dystrophy (BMD) which is a form of muscular dystrophy and causes progressive muscle weakness. ...
•
Season 3
•
Episode 3
•
32:58
.jpg)
Exploring Canada's market access landscape with Sam Stankovic, Incyte Biosciences Canada
Sam is Head of Market Access Canada at Incyte Biosciences Canada and joins the podcast to discuss the evolving market access landscape in Canada. As part of his conversation with Louise, he describes the unique challenges that market access lea...
•
Season 3
•
Episode 2
•
20:16
.jpg)
Market access challenges and changes: Joao Carrasco talks data, AI and predicting uncertainties
In this episode we're joined by Joao Carrasco, Director, Global Market Access Team at Bayer Pharmaceuticals. With a 12+ year career spanning both HEOR and Market Access functions, Joao shares his journey and how his strong HEOR background infor...
•
Season 3
•
Episode 1
•
25:31
.jpg)
Sanofi's Becky Germino on communicating value, AI and the role of HEOR in supporting access & pricing leaders
In this episode we look at market access through a different lens. We're joined by Becky Germino who has extensive experience in HEOR across a broad range of pharma organisations. Becky joined Sanofi this year as HEVA, Neurology and Im...
•
Season 2
•
Episode 6
•
29:51
.jpg)
Sharing your market access story and demonstrating value with Biogen’s Adrian Harrington
Adrian Harrington, Senior Director Value and Access at Biogen, joins the podcast to discuss market access excellence – what it means to him, and the critical role visual communication is playing for market access leaders.Adrian also shar...
•
Season 2
•
Episode 5
•
23:57
.jpg)
Digitalisation of Market Access with Thomas Gilboy and Shravani Madishetti
In this special episode, Louise teams up with colleagues Thomas Gilboy and Shravani Madishetti from Access Infinity to explore the transformative impact of digital on market access. Shravani, APAC Pricing and Market Access Lead, highlights the ...
•
Season 2
•
Episode 4
•
24:39
.jpg)
Finding fun in Market Access with Khalid Mirza, Daiichi Sankyo
In the third episode of series 2, Louise interviews Khalid Mirza, Senior Director, Global Market Access & Pricing, Oncology at Daiichi Sankyo. They discuss Khalid's journey into market access, and how, for him, it's evolved into an...
•
Season 2
•
Episode 3
•
29:28
.jpg)
Inspiring professional growth within Market Access with Nick Proctor
In this episode Louise teams up with Access Infinity Partner, Nick Proctor. Nick has been a consultant in the biopharmaceutical industry for over twenty years and shares his views on the hot topics and trends which he feels will have the bigges...
•
Season 2
•
Episode 2
•
24:25
.jpg)
Taking on new challenges in Market Access with David McConkey, Gilead Sciences
Welcome back to the Market Access Matters podcast! In the first episode of series 2, Louise interviews David McConkey, Virology and Oncology Global Value and Access Director at Gilead Services. Having started his career in consulting a...
•
Season 2
•
Episode 1
•
20:15
.jpg)
Women Leaders in Market Access: Katie Gardner, Astellas, talks digital, building high performing teams and recognising that ideas can come from anywhere
In this episode we’re joined by Katie Gardner, who is Head of Global Market Access Excellence at Astellas. We hear Katie’s insights on the changing landscape of market access and what it demands from teams in terms of agility and innovation. Sh...
•
Season 1
•
Episode 8
•
23:17
.jpg)
Women Leaders in Market Access: Pfizer's Séverine Baquart on the critical role of market access and negotiation best practices
In this episode we're joined by Pfizer's Director Global Market Access for Medical Dermatology, Séverine Baquart. Séverine's career spans over twenty years at Pfizer, where she's seen significant change including the separation of the market ac...
•
Season 1
•
Episode 7
•
12:43
.jpg)
Women Leaders in Market Access: Shravani Madishetti on understanding client data and insight needs
Shravani Madishetti is Access Infinity's APAC Pricing and Market Access Lead. Before taking on this role, Shravani specialised in pricing and market access for Novartis, where she was based for over seven years. She now leads a team that suppor...
•
Season 1
•
Episode 6
•
13:31
.jpg)
Women Leaders in Market Access: Paula Albuquerque, UCB, talks purpose, intension setting and bringing science to market
In this episode we're joined by Paula Albuquerque, who is Director Global Market Access Immuno - Rheumatology at UCB. Paula has a comprehensive global background within the healthcare, pharmaceutical, biotech and management consulting sectors a...
•
Season 1
•
Episode 5
•
25:37
.jpg)
Women Leaders in Market Access: Client Success Manager, Cloë Carey on trusting instincts and what makes market access rewarding
In this episode, Louise interviews Access Infinity's Client Success Manager Cloë Carey. Cloë and her surrounding team are pioneering digital transformation in pharma and specifically, market access. They discuss Cloë's natural interest...
•
Season 1
•
Episode 4
•
21:22
.jpg)